Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Decellularized Human Gut as a Natural 3D Platform for Research in Intestinal Fibrosis.

Giuffrida P, Curti M, Al-Akkad W, Biel C, Crowley C, Frenguelli L, Telese A, Hall A, Tamburrino D, Spoletini G, Fusai G, Tinozzi FP, Pietrabissa A, Corazza GR, De Coppi P, Pinzani M, Di Sabatino A, Rombouts K, Mazza G.

Inflamm Bowel Dis. 2019 Jun 14. pii: izz115. doi: 10.1093/ibd/izz115. [Epub ahead of print]

PMID:
31199863
2.

Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study.

Ciccocioppo R, Bozzini S, Betti E, Imbesi V, Klersy C, Lakyova LS, Sukovsky L, Benacka J, Kruzliak P, Corazza GR, Di Sabatino A, Falcone C.

Clin Exp Med. 2019 Jun 7. doi: 10.1007/s10238-019-00562-x. [Epub ahead of print]

PMID:
31175506
3.

From sadness to stiffness: the spleen's progress.

Riva MA, Ferraina F, Paleari A, Lenti MV, Di Sabatino A.

Intern Emerg Med. 2019 May 31. doi: 10.1007/s11739-019-02115-2. [Epub ahead of print] Review.

PMID:
31152307
4.

A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.

Fiorino G, Sturniolo GC, Bossa F, Cassinotti A, di Sabatino A, Giuffrida P, Danese S.

Cells. 2019 May 30;8(6). pii: E523. doi: 10.3390/cells8060523.

5.

Determinants of diagnostic delay in autoimmune atrophic gastritis.

Lenti MV, Miceli E, Cococcia S, Klersy C, Staiani M, Guglielmi F, Giuffrida P, Vanoli A, Luinetti O, De Grazia F, Di Stefano M, Corazza GR, Di Sabatino A.

Aliment Pharmacol Ther. 2019 May 22. doi: 10.1111/apt.15317. [Epub ahead of print]

PMID:
31115910
6.

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer.

De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R.

Cancers (Basel). 2019 May 10;11(5). pii: E648. doi: 10.3390/cancers11050648.

7.

Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease.

Giuffrida P, Cococcia S, Delliponti M, Lenti MV, Di Sabatino A.

Cells. 2019 Apr 30;8(5). pii: E397. doi: 10.3390/cells8050397. Review.

8.

Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.

Vanoli A, Albarello L, Uncini S, Fassan M, Grillo F, Di Sabatino A, Martino M, Pasquali C, Milanetto AC, Falconi M, Partelli S, Doglioni C, Schiavo-Lena M, Brambilla T, Pietrabissa A, Sessa F, Capella C, Rindi G, La Rosa S, Solcia E, Paulli M.

Am J Surg Pathol. 2019 Jun;43(6):725-736. doi: 10.1097/PAS.0000000000001234.

PMID:
30913089
9.

The role of interleukin-13 in chronic inflammatory intestinal disorders.

Giuffrida P, Caprioli F, Facciotti F, Di Sabatino A.

Autoimmun Rev. 2019 May;18(5):549-555. doi: 10.1016/j.autrev.2019.03.012. Epub 2019 Mar 4. Review.

PMID:
30844559
10.

A modification of the leaf-bags method to assess spring ecosystem functioning: benthic invertebrates and leaf-litter breakdown in Vera Spring (Central Italy).

Cristiano G, Cicolani B, Miccoli FP, Di Sabatino A.

PeerJ. 2019 Feb 13;7:e6250. doi: 10.7717/peerj.6250. eCollection 2019.

11.

Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells.

Burrello C, Pellegrino G, Giuffrè MR, Lovati G, Magagna I, Bertocchi A, Cribiù FM, Boggio F, Botti F, Trombetta E, Porretti L, Di Sabatino A, Vecchi M, Rescigno M, Caprioli F, Facciotti F.

Life Sci Alliance. 2019 Feb 13;2(1). pii: e201800229. doi: 10.26508/lsa.201800229. Print 2019 Feb.

12.

Small Bowel Carcinomas Associated with Immune-Mediated Intestinal Disorders: The Current Knowledge.

Giuffrida P, Vanoli A, Arpa G, Bonometti A, Luinetti O, Solcia E, Corazza GR, Paulli M, Di Sabatino A.

Cancers (Basel). 2018 Dec 29;11(1). pii: E31. doi: 10.3390/cancers11010031. Review.

13.

Reflux symptoms in professional opera soloists.

Lenti MV, Cammarota G, Vidali F, Masala G, Bendinelli B, Gasbarrini G, Corazza GR, Di Sabatino A.

Dig Liver Dis. 2019 Jun;51(6):798-803. doi: 10.1016/j.dld.2018.11.026. Epub 2018 Dec 4.

PMID:
30578108
14.

Mortality rate and risk factors for gastrointestinal bleeding in elderly patients.

Lenti MV, Pasina L, Cococcia S, Cortesi L, Miceli E, Caccia Dominioni C, Pisati M, Mengoli C, Perticone F, Nobili A, Di Sabatino A, Corazza GR; REPOSI Investigators.

Eur J Intern Med. 2019 Mar;61:54-61. doi: 10.1016/j.ejim.2018.11.003. Epub 2018 Dec 4.

PMID:
30522789
15.

Intestinal fibrosis.

Lenti MV, Di Sabatino A.

Mol Aspects Med. 2019 Feb;65:100-109. doi: 10.1016/j.mam.2018.10.003. Epub 2018 Nov 2. Review.

PMID:
30385174
16.

Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition.

Mehta SJ, Lewis A, Nijhuis A, Jeffery R, Biancheri P, Di Sabatino A, Feakins R, Silver A, Lindsay JO.

J Cell Mol Med. 2018 Nov;22(11):5617-5628. doi: 10.1111/jcmm.13836. Epub 2018 Sep 6.

17.

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V; PROSIT Investigators .

Inflamm Bowel Dis. 2019 Feb 21;25(3):568-579. doi: 10.1093/ibd/izy264.

PMID:
30137352
18.

Vaccine Immunotherapy for Celiac Disease.

Di Sabatino A, Lenti MV, Corazza GR, Gianfrani C.

Front Med (Lausanne). 2018 Jun 26;5:187. doi: 10.3389/fmed.2018.00187. eCollection 2018.

19.

How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease.

Naviglio S, Giuffrida P, Stocco G, Lenti MV, Ventura A, Corazza GR, Di Sabatino A.

Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):797-810. doi: 10.1080/17474124.2018.1494573. Epub 2018 Jul 6. Review. Erratum in: Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):ix.

PMID:
29957083
20.

Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.

Vanoli A, La Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, Persichella A, Martino M, Inzani F, Luinetti O, Di Sabatino A, Sessa F, Paulli M, Corazza GR, Rindi G, Bordi C, Capella C, Solcia E.

Neuroendocrinology. 2018;107(2):114-126. doi: 10.1159/000489902. Epub 2018 Jun 12.

PMID:
29895024

Supplemental Content

Loading ...
Support Center